FDA Drug recall D-1396-2012
Mefloquine HCL Tablets, 250 mg, 5 tablets per blister pack
- FDA Drug
- Class II
- terminated
- Published 2012-07-04
On 2012-07-04 the FDA classified a Class II recall of Mefloquine HCL Tablets, 250 mg, 5 tablets per blister pack by Teva Pharmaceuticals Usa, citing tablet Thickness: Product is being recalled due to the potential of being underweight or overweight.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1396-2012 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2012-04-02 |
| Published | 2012-07-04 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Teva Pharmaceuticals Usa |
| Distribution | US |
Product
Mefloquine HCL Tablets, 250 mg, 5 tablets per blister pack; 5 Blister packs per carton, Rx only, Teva Pharmaceuticals USA Sellersville, PA 18960, Individual blister pack: NDC 0555-0171-88, 25 Unit-Dose Tablets (5x5) Carton: NDC 0555-0171-78
Reason
Tablet Thickness: Product is being recalled due to the potential of being underweight or overweight.
Identifiers
| ndc | 0555-0171-88 |
|---|---|
| ndc | 0555-0171-78 |
| code_info | Lot # 34000741A; Expiration date: 7/2013 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1396-2012%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.